← Back to Search

Tailored Interventions for Cardiovascular Disease

N/A
Waitlist Available
Led By Justin M Bachmann, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inpatients undergoing coronary artery bypass grafting or percutaneous coronary intervention.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-2 days after intervention
Awards & highlights

Study Summary

This trial will study why Veterans with cardiovascular disease don't enroll in cardiac rehabilitation programs and try to develop a behavior intervention to encourage them to do so.

Who is the study for?
This trial is for Veterans hospitalized with cardiovascular disease who are undergoing specific heart procedures and have not been in a cardiac rehab program recently. It's not for those with certain mental conditions, near end of life, under police custody, uncooperative, or with severe hearing or vision impairments.Check my eligibility
What is being tested?
The study tests a personalized behavioral intervention to encourage these Veterans to enroll in outpatient cardiac rehabilitation programs. The approach uses surveys and interviews to tailor the support based on individual barriers and motivation theories.See study design
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medications, traditional side effects like you might see with drugs aren't expected. However, participants may experience stress or discomfort during interviews or assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am in the hospital for a procedure to improve blood flow to my heart.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-2 days after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-2 days after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Qualitative interviews

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tailored interventionExperimental Treatment1 Intervention
Tailored intervention designed to address individual barriers to cardiac rehabilitation participation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tailored intervention
2009
N/A
~410

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,605 Previous Clinical Trials
3,305,571 Total Patients Enrolled
Justin M Bachmann, MD MPHPrincipal InvestigatorTennessee Valley Healthcare System Nashville Campus, Nashville, TN

Media Library

Tailored intervention Clinical Trial Eligibility Overview. Trial Name: NCT05214989 — N/A
Cardiovascular Disease Research Study Groups: Tailored intervention
Cardiovascular Disease Clinical Trial 2023: Tailored intervention Highlights & Side Effects. Trial Name: NCT05214989 — N/A
Tailored intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05214989 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively recruiting participants?

"According to the data published on clinicaltrials.gov, this particular medical trial is no longer recruiting patients as it was last edited in January 18th 2022. However, there are 428 other trials that require enrolment of participants at present time."

Answered by AI
~17 spots leftby Dec 2025